Home › NDC Lookup › Ingredients › Brinzolamide › 24208-0464-15
👁️image loading
(from DailyMed)

BRINZOLAMIDE 10 mg/mL Suspension/ Drops — NDC 24208-464-15 (Billing 24208-0464-15)

by Bausch & Lomb Incorporated · 1 BOTTLE, PLASTIC in 1 CARTON / 15 mL in 1 BOTTLE, PLASTIC

This is a package of BRINZOLAMIDE 10 mg/mL Suspension/ Drops from Bausch & Lomb Incorporated, marketed since Mar 2022 and currently FDA-listed; retail pharmacies pay about $9.47 per mL (NADAC).

NDC 24208-0464-15
🏷️ FDA NDC (as labeled) 24208-464-15 billing pads the product segment with a zero
This package
Contains15 mL in 1 bottle, plastic Cost per mL$9.47 NADAC Per package$142.11 / 15 ml Pack sizes2 compare ↓
Also priced by: Part D plans $13.69/unit — full pricing hub ↓
Product page 24208-0464-10 Also comes in: 10 mL 24208-464-10
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 24208-464-15 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
24208 labeler · 464 product · 15 package
Package marketed since
Mar 31, 2022
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 2420846415 1
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 24208-464-15
Product NDC 24208-464
11-digit billing NDC 24208046415
NCPDP billing unit ML — per mL (volume)
Application # ANDA204884
SPL Set ID 5c9024fa-2a68-9853-e063-6294a90a7bae
Established class (EPC) Carbonic Anhydrase Inhibitor
Mechanism of action Carbonic Anhydrase Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-03-31
Route OPHTHALMIC
Dosage form SUSPENSION/ DROPS
Substance BRINZOLAMIDE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 039498
GCN 95773
HICL code 018254
Ingredient (HICL) Brinzolamide
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6G
Therapeutic class — specific (HIC3) Miotics And Other Intraocular Pressure Reducers
AHFS code 52:40.12.00
AHFS class Carbonic Anhydrase Inhibitors (52:40)
FDB label name BRINZOLAMIDE 1% EYE DROPS
FDB brand name Brinzolamide
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 039498
  • GCN: 95773
  • HICL (First Databank): 018254
  • AHFS class code: 52:40.12.00
Why two NDCs? The FDA registers this code as 24208-464-15 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24208-0464-15. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name BRINZOLAMIDE 1% EYE DROPS Ingredient Brinzolamide
📗 Our plain-language guide HelloPharmacist
  • Brinzolamide lowers high pressure inside your eye. It is used for ocular hypertension and open-angle glaucoma. Keeping eye pressure down helps protect the optic nerve from damage.
  • It is generally one drop in the affected eye(s) 3 times a day, but follow your prescriber's directions. Shake the bottle well first. If you use other eye drops, wait at least 10 mi...
  • The most common are blurred vision and a bitter, sour, or unusual taste. Some people get eye discomfort, dryness, itching, or redness. Blurred vision can be a problem for a bit aft...
  • Stop and get help right away if you develop a severe rash, blistering or peeling skin, or other signs of a serious allergic reaction. This drop is a sulfonamide, and rarely those r...
📖 Read our full Brinzolamide Ophthalmic guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Brinzolamide — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Brinzolamide (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $9.474 $142.11 / 15 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $13.69 $205.33 / 15 ml
NADAC price history (per mL) — tap or hover for the price & month
Nov 2025 Mar 2026 Jun 2026 Sep 2026 $14.301 $9.474
▼ Down 24% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
24208-0464-10 24208-464-10 Main listing 1 BOTTLE, PLASTIC in 1 CARTON / 10 mL in 1 BOTTLE, PLASTIC $8.53 / mL $85.26 2022-03-31 — Active
24208-0464-15 You're viewing this 1 BOTTLE, PLASTIC in 1 CARTON / 15 mL in 1 BOTTLE, PLASTIC $9.47 / mL $142.11 2022-03-31 — Active

Per mL, this pack runs about 11% above the cheapest pack (NDC 24208-0464-10, $8.53 vs $9.47 NADAC).

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 bottle, plastic in 1 carton / 15 ml in 1 bottle, plastic.
What NDC number is used to bill for this package of BRINZOLAMIDE 10 mg/mL Suspension/ Drops?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Brinzolamide 10 mg/mL 00574-4012-10 Padagis 1 bottle $8.526 — Availability likely save 10%
Brinzolamide 10 mg/mL 00781-6014-70 Sandoz 1 bottle $8.526 AB Availability likely save 10%
Brinzolamide 10 mg/mLthis 24208-0464-15 Bausch 1 bottle $9.474 AB Availability likely —
Brinzolamide 10 mg/mL 68682-0464-10 Oceanside 1 bottle $14.766 AB FDA listed +56%
Azopt 10 mg/mL 66758-0085-70 Sandoz 1 bottle $35.063 AB Availability likely +270%
Brinzolamide 10 mg/mL 72162-2201-02 Bryant 1 bottle — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Mar 2022
📍
2026
Currently FDA-listed
4 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Brinzolamide Ophthalmic inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBausch & Lomb Incorporated
Application holderBAUSCH AND LOMB INC
FDA applicationANDA204884 (ANDA)
Labeler code24208
First marketedMar 2022
Product typeHuman Prescription Drug
Portfolio92 products on file

More NDCs from Bausch & Lomb Incorporated labeler code 24208

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 bottle24208-0464-10 52 Rx · $6,044
1 bottle this page24208-0464-15 No Medicaid data
Drug total (last 4 qtrs): 52 Rx · 510 units · $6,044 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Brinzolamide — the program that covers self-administered drugs. 4 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Brinzolamide. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$9.02M
Claims incl. refills
42K
Beneficiaries
28.6K
Spend / beneficiary
$315.93
Spend / claim
$214.90
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 24208-0463-25 · Bausch 24208-0485-10 · Bausch →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.